Management of the Difficult Gallbladder

                                                                                       

 

 

 

     

This course is part of a series highlighting selected panel sessions from Clinical Congress 2023.  Upon registration, you will have access to the recording of the original session in Boston and the recording from the live webinar on June 27, 2024.  The webinar expands on information discussed in the original session, providing additional commentary and allowing for a deeper understanding of the content.

The difficult gallbladder remains a challenge in surgical practice. This session will explore safe and effective strategies to approach the patient with severe acute cholecystitis. In addition, the topic of cholecystectomy in the cirrhotic patient will also be explored as will techniques for managing the difficult gallbladder in a rural setting.

 

Target Audience

  • Practicing Surgeons
  • Residents
  • Medical Students

Learning Objectives

At the conclusion of the course, participants should be able to do the following:  

  • Outline the treatment options and techniques for managing acute cholecystitis in surgical patients.
  • Describe patient selection and surgical techniques in patients with cirrhosis and gallbladder disease.
  • Detail special challenges and techniques for managing acute cholecystitis in the rural setting.

 

Contact

Course summary
Available credit: 
  • 2.50 AMA PRA Category 1 Credit™
  • 2.50 Certificate of Completion
Course opens: 
06/06/2024
Course expires: 
10/04/2024

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

American College of Surgeons Program Committee Disclosures

Fabrizio Michelassi, MD, FACS, MAMSE - Tsumura, Inc.
Sharmila Dissanaike, MD, FACS, FCCM - Heron Therapeutics
Brooke C. Bredbeck, MD - Nothing to disclose
Kellie R. Brown, MD, FACS - Nothing to disclose
Yolanda L. Colson, MD, PhD, FACS - Canon USA; Stryker
Cynthia D. Downard, MD, MMSc, FACS, FAAP - Nothing to disclose
Quan-Yang Duh, MD, FACS - Nothing to disclose
Neal D. Futran, MD, DMD, FACS - Stryker
B.J. Hancock, MD, FRCSC, FACS - Nothing to disclose
Jonathan A. Laryea, MBChB, FACS, FASCRS, FWACS - Nothing to disclose
Amy E. Liepart, MD, FACS -  Nothing to disclose
Ronald V. Maier, MD, FACS, FRCSED(Hon), FCSHK(Hon), FCCS(Hon), FISS(Hon), MAMSE - Nothing to disclose
Viraj Master, MD, PhD, FACS - Ethicon; Exelixis
Nipun B. Merchant, MD, FACS -  Nothing to disclose
Susan C. Modesitt, MD, FACOG, FACS - Nothing to disclose
Nicolas J. Mouawad, MD, MPH, MBA, FSVS, FACS, FRCS, RPVI - Nothing to disclose
Lena Napolitano, MD FACS, MAMSE - Nothing to disclose
M. Timothy Nelson, MD, FACS, DABS - Nothing to disclose
Patrick R. Reardon, MD, FACS - Nothing to disclose
Mark T. Savarise, MD, MBA, FACS - Nothing to disclose
Kenneth W. Sharp, MD, FACS, MAMSE - Nothing to disclose
Ali Tavakkoli, MBBS, FACS - AltrixBio
Steve D. Wexner, MD, PhD (Hon), FACS, FRCS (Eng), FRCS(Ed), FRCSI (Hon), Hon FRCS (Glasg), Hon FRCS (Eng), MAMSE - Baxter; BD (Becton, Dickinson & Co); Glaxo Smith Kline; Intuitive Surgical; Livsmed; Medtronic; OstomyCure; Stryker; Takeda; Virtual Ports; JSR/WCG/ACI; Polypid; Boomerang; Intuitive Surgical; Karl Storz Endoscopy America Inc; Unique Surgical Innovations LLC; Intuitive Surgical; Pragma/GibLib; Renew Medical

Faculty Disclosures

Bryan K. Richmond, MD, MBA, FACS - Nothing to disclose.
Charles S. Parsons, MD, FACS - Nothing to disclose.
Andrew B. Peitzman, MD, FACS - Nothing to disclose.
Carl R. Schmidt, MD, FACS - Nothing to disclose.
Michael D. Sarap, MD, FACS - Nothing to disclose.
Clancy J. Clark, MD, FACS - Nothing to disclose.
Morgan Hennessy, MD, PhD - Nothing to disclose.

 

Continuing Medical Education Credit Information

Accreditation

The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this Other activity for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

American College of Surgeons and ACGME Logos

 

CME Credit Claiming Information

 

This course is available for claiming partial credit, for AMA PRA Category 1 Credits ™.  

 

All attendees must complete the course evaluation in order to claim a CME Certificate or a Certificate of Completion. The course evaluation will appear once you take and complete this course. The following requirements will need to be completed:

  • Review all course materials 
  • Course evaluation

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.

 

Available Credit

  • 2.50 AMA PRA Category 1 Credit™
  • 2.50 Certificate of Completion
Please login or register to take this course.

Course Fee and Registration

The following is the course fee for each category. You will be asked to register for the course and provide payment information to complete the registration process. 

  • Clinical Congress attendees/Medical students - complimentary
  • Resident members - $20
  • Fellows and Affiliate MD/DO -  $55
  • Non-members -  $75

Once you have completed the registration process, a confirmation email will be sent to you with the course information.

 

To Start Course

Once you have completed the registration process, you will see the "Take Course" button above.  Click on the button to start/access the educational activity.  The original panel session and the recording of the webinar are available on the course page. Access to the course and CME credit claiming will close on Friday, September 27, 2024.